Find clinical trials for Pancreatic Cancer in Detroit, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Pancreatic Cancer trials near Detroit, MI, USA:
receiving lower radiation doses, in patients with locally advanced pancreatic cancer, without increasing the rate of serious gastro...
Detroit, Michigan, United States and 12 other locations
open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...
Phase 1, Phase 2
Detroit, Michigan, United States and 15 other locations
Antroquinonol is proposed for the treatment of neoplasms. The proposed clinical trial is a Phase I/II study designed to evaluate antroquinon ...
Phase 1, Phase 2
Detroit, Michigan, United States and 8 other locations
in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreat...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 11 other locations
with mFOLFIRINOX (folinic acid, 5-FU, irinotecan, oxaliplatin) to mFOLFIRINOX alone in patients with advanced and unresectable or metastatic pancreatic...
Phase 2, Phase 3
Detroit, Michigan, United States and 1 other location
compared to just chemotherapy alone in participants with metastatic pancreatic cancer. One group of participants will only receive ...
Phase 2
Ann Arbor, Michigan, United States and 35 other locations
or without SBP-101 in subjects previously untreated for metastatic pancreatic ductal adenocarcinoma (PDA), including subjects who have recei...
Phase 2, Phase 3
Detroit, Michigan, United States and 91 other locations
PK, and PD of SON-DP in participants with relapsed/refractory/intolerant to standard of care therapies, for advanced/ metastatic solid tumors...
Phase 1
Detroit, Michigan, United States and 4 other locations
evaluate the efficacy, safety, and tolerability of futibatinib in combination with PD-1 antibody-based SoC therapy in adult patients with solid tumors...
Phase 2
Detroit, Michigan, United States and 21 other locations
(with enzalutamide-naïve metastatic castration-resistant prostate cancer) will be randomized to receive either NUV-868 monotherapy, enzaluta...
Phase 1, Phase 2
Detroit, Michigan, United States and 30 other locations
Clinical trials
Research sites
Resources
Legal